Currently specializing in tattoo inks that are both permanent and removable, Freedom2 is working on a host of skin care applications for its Particle Encapsulation Delivery System (PEDS).
The patented technology can be used to encapsulate pigments, dyes and pharmaceuticals in aesthetic, cosmetic and therapeutic skin care products.
Ingredients are encapsulated in microscopic polymer beads that can vary in size and construction because of the type of polymer used.
The beads can also be biodegradable.
Technology applications This is particularly useful for pharmaceutical products because the beads can erode delivering precise doses of ingredients into the skin at, or over, specific times.
Freedom2 said researchers working on treatment resistant diseases, such as hepatitis and AIDS, are reviewing PEDS as a drug delivery system.
For the cosmetics industry the company is working on a sun-block solution, NBlock, which encapsulates titanium dioxide in microscopic polymer beads to prevent the compound from penetrating the skin's surface.
The firm is also working on Clear, a new facial rejuvenation product using a version of PEDS, which aims to soften fine lines and wrinkles around the eyes and lips.
The product is expected to become available in 2009 through cosmetic aestheticians.
Market opportunities Freedom2 CEO Martin Schmieg said: "Our research scientists and market specialists are at work refining and preparing new products.
"Including both direct and collaborative market opportunities, our annual product pipeline is projected to bring in excess of $1bn in annual revenues."
PEDS technology platform uses three methods of encapsulation: single-emulsion solvent evaporation, double-emulsion solvent evaporation, and spray dry solvent evaporation.
Freedom-2 has developed pilot-scale processes (up to 100 gram/batch) and is currently developing commercial scale capabilities.